Bradley Merrill ThompsoninTowards Data SciencePostmarket Responsibilities for Medical AIPart III — FDA Should Not Expand Its Oversight of Commercialized AIJul 1, 2020Jul 1, 2020
Bradley Merrill ThompsoninTowards Data SciencePostmarket Responsibilities for Medical AIPart II — What Industry Should Do in Commercializing Medical AIJun 25, 2020Jun 25, 2020
Bradley Merrill ThompsoninTowards Data SciencePostmarket Responsibilities for Medical AI: Part I — FDA’s Plan to Increase Its OversightThere is an elephant in the room. Tension in the air that we need to discuss. FDA is trying to convince artificial intelligence developers…Jun 18, 2020Jun 18, 2020